Skip to main content
. 2022 Mar 18;27(6):1977. doi: 10.3390/molecules27061977

Figure 3.

Figure 3

MRM LC-MS/MS chromatograms of ARV-110 (left) and pomalidomide (right) after deproteinization of blank mouse plasma (a); zero calibrator (b); LLOQ (c); and mouse plasma sample 60 min after PO administration of ARV-110 at a dose of 2 mg/kg (d).